EWOC-1 (Elderly Women Ovarian Cancer) Trial:
Multicenter, randomized trial of carboplatin +/- paclitaxel in vulnerable elderly patients with stage III-IV advanced ovarian cancer.
Phase III international, randomized study of Trabectadin plus Pegylated Liposomal Doxorubicin (PLD) versus Carboplatin plus PLD in patients with relapsed ovarian cancer progressing within 6-12 months of last platinum. This study evaluates if the combination of trabectadin (Yondelis) and PLD prolongs overall survival (OS) over carboplatin and PLD in this patient population. A total of 588 are planned.
ENGOT – EN2 DGCG/EORTC 55102
A Phase III Trial of Postoperative Chemotherapy or no Further Treatment for Patients With Node-negative Stage I-II Intermediate or High Risk Endometrial Cancer.